CYP3A4 polymorphisms - potential risk factors for breast and prostate cancer: a huge review
about
Application of oligonucleotide microarray technology to toxic occupational exposuresCalcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic InteractionsA perspective on the role of estrogen in hormone-induced prostate carcinogenesisFunctionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping testsReview of studies on metabolic genes and cancer in populations of African descent.Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.Minireview: Nuclear receptor-controlled steroid hormone synthesis and metabolismThe frameshift polymorphism CYP3A43_74_delA is associated with poor differentiation of breast tumors.IN VIVO EFFECT OF RUTA CHALEPENSIS EXTRACT ON HEPATIC CYTOCHROME 3A1 IN RATS.Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologistsPregnane X receptor as a therapeutic target to inhibit androgen activity.Role of hormonal and other factors in human prostate cancer.Relationship between genotypes Sult1a2 and Cyp2d6 and tamoxifen metabolism in breast cancer patientsClinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.Hormones and prostate carcinogenesis: Androgens and estrogens.Hypolipidemic agent Z-guggulsterone: metabolism interplays with induction of carboxylesterase and bile salt export pumpThe ABCB1 3435 T allele does not increase the risk of paclitaxel-induced neurotoxicityTolfenamic acid suppresses cytochrome P450 2E1 expression in mouse liverAssociations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race.Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model.Clinical implications of CYP3A polymorphisms.Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the "Missing Heritability" ProblemPhase I and Phase II enzyme polymorphisms and childhood cancer.Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.Pharmacogenetics of acute lymphoblastic leukemia treatment response.Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications.Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association ConsortiumPolymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent.Molecular population genetics of human CYP3A locus: signatures of positive selection and implications for evolutionary environmental medicine.Gender and interindividual variability in pharmacokinetics.Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.Pharmacogenomics of third-generation aromatase inhibitors.CYP3A4*1B polymorphism and cancer risk: a HuGE review and meta-analysis.Molecular pathways in prostate cancer.CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy.Cytochrome and sulfotransferase gene variation in north African populations.CYP3A variation, premenopausal estrone levels, and breast cancer risk.ChIP-seq analysis of androgen receptor in LNCaP cell line.
P2860
Q23918078-821B79C8-03C7-4328-9F53-1EDAF2EA5F68Q26766242-91FA3A07-4899-47D5-A123-2960117F4E3CQ27004552-D411DA01-8A05-4710-A3A9-DE9D87B18F54Q28260518-B12DD675-E559-4D5B-B69A-C61131D94342Q30494890-01143F1D-4468-4B01-843A-2DF30306DAE3Q33289676-FCEC1798-2B44-4B3F-8D8C-DACB5982A481Q33579464-4857FAAB-2009-4E2C-A344-86729AF9D316Q33660484-C3F38405-BFED-418F-9039-7BD746806679Q33800457-E183D6A2-2DF4-4E44-BCDA-F169432506ACQ33813463-FDEE32F1-A2A1-4319-848F-51BB02F5F782Q34392652-C9EE3AC2-9CCE-4C9D-8A85-237ADDD42CDCQ34764764-6ACE56AE-1483-4F25-81AC-409CF784A62EQ34906432-55D9759A-593B-4F96-9691-56C903E36717Q35058455-F347851C-269A-4245-BDCE-FD1D77CF0E08Q35687198-4E724AB2-3469-447D-AEFE-AB234E71DFFAQ35747799-FE404352-4412-412B-B93B-3FC0F5897356Q36216741-13EC96F0-7D0C-428F-B17B-2B21532DE66DQ36217454-9746A73E-58FC-4CA6-B817-88F0B1AA25C4Q36295179-121B4AB0-B664-4BB5-84A0-19314FF0FFF8Q36365599-320D750F-8783-4274-9EA4-84EE676297D1Q36430744-6EC331DD-44C4-452D-B38F-1D57BC80B977Q36546247-219E8A26-9E9C-47F1-A00E-7428B1F52D29Q36634077-B359A2CC-4384-48F2-B825-0CEC6E30A43CQ36668333-5AF161EF-07C1-4926-AC98-50E0490E769DQ36696957-F4327720-2F76-42BF-9CCD-FC3F15E85322Q36968156-16A9F842-571F-49B2-AA04-C4BCDB4773CFQ37016023-0F093517-8CAB-455D-B3B0-A70CBB840E33Q37081074-CF043F09-08B9-41CC-AA02-09AA6F75401EQ37436048-D20AD802-B9DE-4EFE-A0DC-BF89C9D62D7BQ37465914-F7A155CE-10B8-477A-B80E-24D676E72E62Q37550556-0853D1A3-15D9-4B7C-AE8E-9E11ED353744Q37807282-F620EB58-31D6-43F2-9FAA-E502EE63EA2BQ38010777-B59635CA-3553-4331-835E-E65D99D093F7Q38062357-5E90AF28-7A2B-4B95-B86E-5F03FEA49CC1Q38166735-95C1B725-A303-42A8-9D48-8C26295A2C8BQ38409787-BE7695F6-B972-4F16-AB07-0F9960489A96Q38806725-80DCCA16-4BC7-4CC2-8F0C-D1C81ACDAAD9Q39003041-224474ED-606B-4432-ADBB-26AAF2C138BCQ44288178-03240749-1716-47DC-AE82-CE7FBBD3E633Q45915898-6E3C25DF-F47D-4334-8CF6-CC0DE070F789
P2860
CYP3A4 polymorphisms - potential risk factors for breast and prostate cancer: a huge review
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
CYP3A4 Polymorphisms--Potentia ...... Prostate Cancer: A HuGE Review
@nl
CYP3A4 polymorphisms - potenti ...... prostate cancer: a huge review
@ast
CYP3A4 polymorphisms - potenti ...... prostate cancer: a huge review
@en
CYP3A4 polymorphisms - potenti ...... prostate cancer: a huge review
@en-gb
type
label
CYP3A4 Polymorphisms--Potentia ...... Prostate Cancer: A HuGE Review
@nl
CYP3A4 polymorphisms - potenti ...... prostate cancer: a huge review
@ast
CYP3A4 polymorphisms - potenti ...... prostate cancer: a huge review
@en
CYP3A4 polymorphisms - potenti ...... prostate cancer: a huge review
@en-gb
prefLabel
CYP3A4 Polymorphisms--Potentia ...... Prostate Cancer: A HuGE Review
@nl
CYP3A4 polymorphisms - potenti ...... prostate cancer: a huge review
@ast
CYP3A4 polymorphisms - potenti ...... prostate cancer: a huge review
@en
CYP3A4 polymorphisms - potenti ...... prostate cancer: a huge review
@en-gb
P921
P356
P1476
CYP3A4 polymorphisms--potentia ...... prostate cancer: a HuGE review
@en
P2093
Ainsley Weston
Erin C McCanlies
P2880
P304
P356
10.1093/AJE/KWH294
P407
P577
2004-11-01T00:00:00Z